Live Breaking News & Updates on Vera therapeutics

Stay informed with the latest breaking news from Vera therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vera therapeutics and stay connected to the pulse of your community

Could This Stock Be the Next Biotech Buyout?

Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.

Nvidia , Alpine-immune-sciences , Vertex-pharmaceuticals , Centers-for-disease , Vera-therapeutics , Wall-street , Motley-fool-stock-advisor , Stock-advisorservice , Ertex-pharmaceuticals , Hronic-kidney-disease , Harmaceutical-companies

Vertex Stock: Alpine Accelerates To Become Biotech Powerhouse (NASDAQ:VRTX)

Vertex Stock: Alpine Accelerates To Become Biotech Powerhouse (NASDAQ:VRTX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Saudi-arabia , United-kingdom , Bahrain , United-states , Australia , American , America , Charles-wagner , Reshma-kewalramani , Knoll-pharmaceuticals , Vertex-pharmaceuticals , American-society-of-nephrology

Vertex To Buy Alpine - Why This Deal Feels Slightly 'Vanilla'

Vertex To Buy Alpine - Why This Deal Feels Slightly 'Vanilla'
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Australia , America , Trikafta-kaftrio , Otsuka-pharma , Drug-agency , Vertex-pharmaceuticals-incorporated , Nasdaq , Alpine-immune-sciences-inc , Gilead-sciences

Biotech Stocks Heat Up As Arvinas Scores Licensing Deal And Janux Reportedly Explores Options

Biotech Stocks Heat Up As Arvinas Scores Licensing Deal And Janux Reportedly Explores Options
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Novartis , Bloomberg , Alpine-immune-sciences , Vertex-pharmaceuticals , Arvinas-therapeutics , Janux-therapeutics , Vera-therapeutics ,

Vera Therapeutics (NASDAQ:VERA) Sees Large Volume Increase

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) saw strong trading volume on Thursday . 980,711 shares traded hands during trading, a decline of 21% from the previous session’s volume of 1,245,474 shares.The stock last traded at $43.49 and had previously closed at $41.62. Analysts Set New Price Targets A number of equities analysts have […]

Canada , Raymond-james , Maha-katabi , Royal-bank , Vera-therapeutics-company-profile , Nasdaq , Vera-therapeutics-inc , Securities-exchange-commission , Ameritas-investment-partners-inc , Tower-research-capital , Vera-therapeutics , Get-free-report

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Leerink-smith , Geoff-meacham , Thomas-smith , Vertex-pharmaceuticals , Vertex-pharmaceuticals-adds-to-kidney-diseases-pipeline , Alpine-immune-sciences , Novartis , Otsuka-pharmaceutical , Vera-therapeutics , America-securities

Vertex to Pay $4.9B for Kidney Disease Drug Developer

Vertex to Pay $4.9B for Kidney Disease Drug Developer
themiddlemarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themiddlemarket.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Switzerland , Swiss , Sami-corwin , William-blair , Myles-minter , Alpine-immune-sciences-inc , Vera-therapeutics-inc , Vertex-pharmaceuticals , Nasdaq

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact - Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

William-blair , Alpine-immune-sciences-inc , Vertex-pharmaceuticals-incorporated , Vertex-pharmaceuticals , Alpine-immune-sciences , Vera-therapeutics ,

Vera Therapeutics (NASDAQ:VERA) Earns Buy Rating from Guggenheim

Guggenheim reaffirmed their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $56.00 price target on the stock. Several other brokerages have also commented on VERA. Raymond James raised Vera Therapeutics from an outperform rating to a strong-buy rating and […]

Raymond-james , Maha-katabi , Cantor-fitzgerald , Barclays-plc , Vanguard-group-inc , Capital-partners , Goldman-sachs-group-inc , Vera-therapeutics-inc , Vera-therapeutics , Free-report , Director-maha-katabi , Sachs-group

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […]

Canada , Maha-katabi , Raymond-james , Royal-bank , Vera-therapeutics-inc , Tower-research-capital , Ameritas-investment-partners-inc , Nasdaq , Cantor-fitzgerald , Vera-therapeutics-company-profile , Vera-therapeutics , Get-free-report